8-epi-prostaglandin F2alpha

a potent preglomerular vasoconstrictor acting principally through thromboxane A2 receptor activation

Also Known As:

15-F(2t)-IsoP; 15-F(2t)-isoprostane; 15-F2t-IsoP; 15-F2t-isoprostane; 8-F(2t)-isoprostane; 8-epi-PGF2 alpha; 8-epi-PGF2alpha; 8-epiprostaglandin F2alpha; 8-iso-PGF(2alpha); 8-iso-PGF2alpha; 8-isoprostaglandin F2alpha; 8-isoprostane; isoprostaglandin F2alpha type-III; Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,8beta,9alpha,11alpha,13E,15S)-

Pharmalogical Action Categories:

D014662 - Vasoconstrictor Agents

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins F: 673
        Dinoprost: 1562
        8-epi-prostaglandin F2alpha: 604
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins F: 673
        Dinoprost: 1562
        8-epi-prostaglandin F2alpha: 604

R A Ahokas Selected Research

R A Ahokas Research Topics

Disease

Drug/Important Bio-Agent (IBA)